KB Essential Healthcare 26 DST — DaVita 4-Property Healthcare Portfolio

KB Exchange Trust is pleased to offer this high-quality, real estate investment that is structured as a Delaware Statutory Trust to be eligible as a 1031 exchange investment. This offering consists of four properties totaling approximately 49,500 square feet of medical clinic space and physician offices. These properties have leases guaranteed by DaVita, Inc. (“DaVita”) (NYSE: DVA), a Fortune 500® company, which is a leading provider of kidney care in the United States2. DaVita delivers dialysis services to patients with chronic kidney failure and end-stage renal disease. DaVita is traded on the New York Stock Exchange and boasts a market cap of $7.5 billion. As of year-end 2017, DaVita Health Care Partners has a net worth in excess of $11.4 billion.


Download Investment Summary
Full Name:
E-mail Address:S
Phone Number:
Are You In An Exchange?:
Home Kingsbarn Realty Capital
DST Net-Lease Properties
DST Multifamily Net-Lease
Recent Transactions
DST 101
1031 Exchange
Document Vault

About DaVita Dialysis

DaVita Healthcare Partners, Inc. (“DaVita”) (NYSE: DVA), a Fortune 500® company, is a leading provider of kidney care in the United States and is the guarantor of the lease. DaVita delivers dialysis services to patients with chronic kidney failure and end-stage renal disease. DaVita is traded on the New York Stock Exchange (NYSE: DVA) and boasts a market cap in excess of $7.5 billion. In 2018, DaVita’s consolidated revenue was approximately $11.4 billion and an operating income over $1.5 billion. Approximately 90% of DaVita’s 2018 consolidated revenue was derived directly from the US dialysis related lab series, of which 79% of that revenue was derived from the outpatient hemodialysis centers. The company currently has a Standard & Poor’s rating of “BB” and has experienced tremendous growth over the past decade.

All investment transactions are handled and cleared through First American Title Company, National Commercial Group.


› Offering Price: $18,175,000

› Loan Amount: $9,200,000

› Equity Offering: $8,975,000

› Minimum Investment: $100,000

› Projected Cash Flow (Year 1)1: 6.25%


› 10% Rental Increases Every 5-Years

› Monthly Distributions 1

› Cost segregation studies provided for
  accelerated depreciation

› DST Structure Ideal for 1031 Exchanges

› Investments Starting from $100,000

Call Us To Discuss This Investment Opportunity: 800.242.1000

Ron Glasgow
Managing Director,
KB Exchange Trust

Jeff Farnsworth
Regional VP,
San Francisco

Matt Ayer
Regional VP,
Los Angeles

Matt McQueen
Regional VP,
Orange County

Steven Prescott
Regional VP,
San Diego

(1) An investment in the DST Units is speculative and involves substantial investment and tax risks. There are no guarantees of cash flow, distributions or real estate appreciation. Investors could lose some or all of their investment in the DST Units. Investors are advised to review the Confidential Private Placement Memorandum in its entirety and consult with their own legal, tax, financial and business advisors prior to investing.

(2) The Lewisville property has a portion of the lease to a physician group and is not guaranteed by DaVita. The physician group lease accounts for approximately 13% of the portfolio’s income. The physician group is the former owner of the portfolio.

This website does not offer to sell, or a solicitation of an offer to buy, securities. Offers can only be made through the Private Placement Memorandum which contains various and important risk disclosures. This web site does not purport to be complete and should be viewed in conjunction with the Private Placement Memorandum. An investment of this sort is speculative and involves a high degree of risk. Projections of future performance contained herein are based on specific assumptions discussed more fully in the Private Placement Memorandum and do not constitute a guaranty of future performance.

DST Interests in any of the properties displayed on this website may be sold only to "accredited investors," as defined in Regulation D under the U.S. Securities Act of 1933, as amended (the "Securities Act"), which, for natural persons, refers to investors who meet certain minimum annual income or net worth thresholds. Offers and sales of DST interests have not and will not be registered under the Securities Act or the laws of any U.S. state or non-U.S. jurisdiction and may be offered only pursuant to an exemption from such registration. Neither the U.S. Securities and Exchange Commission nor any other regulatory authority has passed upon the merits of an investment in the DST Interests, has approved or disapproved of DST Interests or passed upon the accuracy or adequacy of this website and any supplementary materials describing the DST Interests. DST Interests are also not subject to the protections of the Investment Company Act of 1940, including the limitations on self-dealing, affiliated transactions and leverage contained therein. DST Interests are subject to legal restrictions on transfer and resale in accordance with the governing documents of the Trust and applicable securities laws, and investors may be unable to sell or transfer their DST interests. In addition, there is no public market for the DST interests and no such market is expected to develop in the future. Investing in the DST securities involves risk, and investors should be able to bear the loss of their investment.

Securities offered through registered representatives of Colorado Financial Service Corporation, Member FINRA and SIPC. Kingsbarn and Colorado Financial Service Corporation are separate entities. Any information provided on this site has been prepared from sources believed to be reliable, but is not guaranteed by Kingsbarn Real Estate Capital or Colorado Financial Service Corporation and is not a complete summary or statement of all available data necessary for making an investment decision. Any information provided is for informational purposes only and does not constitute a recommendation. Check the background of this investment professional on FINRA’s BrokerCheck